Bamboo Splinter

Re: TikTok - It’s a no for Microsoft and a yes for Oracle

Oracle has reportedly been selected as TikTok’s “trusted tech partner”.

The Bamboo Team
Sep 14, 2020 • 1 min read

ByteDance, the owner of TikTok, has reportedly selected Oracle (NYSE: ORCL) as its “trusted tech partner” to manage TikTok’s U.S. cloud operations. This differs from an outright sale of the company’s U.S. assets and it infers that Oracle will help run TikTok’s U.S. operations with its own cloud infrastructure. News of the deal came shortly after Microsoft disclosed that it was no longer acquiring TikTok after its bid was rejected by ByteDance. Click here to read more 

Gilead to acquire cancer drugmaker Immunomedics for $21 billion

Gilead Sciences Inc (NASDAQ: GILD) is set to buy biopharmaceutical company, Immunomedics Inc (NASDAQ: IMMU) for $21 billion. The move will help Gilead to strengthen its cancer portfolio, as it will gain access to Immunomedics breast cancer treatment drug, Trodelvy, which was granted an accelerated FDA approval in April. The transaction is expected to close in the fourth quarter of 2020. Click here to read more 

Nvidia gains SoftBank’s Arm for $40 billion

Nvidia Corp (NASDAQ: NVDA), the biggest U.S chip company by market capitalisation, disclosed that it will buy chip designer Arm from SoftBank Group Corp. for $40 billion. This sale puts a vital chip supplier to Apple Inc and others across the industry under the control of a single player, Nvidia. Nvidia will pay SoftBank $21.5 billion in shares and $12 billion in cash, and SoftBank will take a stake between 6.7% and 8.1% in Nvidia. Click here to read more 

A guide to understanding the stock market

Looking for some insight into what the stock market means and how it works? Download, read and share this stock market guide we prepared just for you. 

Market Movers

Here are the biggest movers in pre-market trading

What else are we reading?

1. Saudi Aramco regains top spot from Apple as tech rally fades. Click here to read more 
2. AstraZeneca shares gain as Covid-19 vaccine trials resume. Click here to read more 

Don’t forget to follow us on InstagramTwitterFacebook and LinkedIn  

That’s all from us.

We will see you tomorrow.

guest
4 Comments
Oldest
Newest
Inline Feedbacks
View all comments
binance valuation
1 year ago

Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

crie uma conta na binance

Thanks for sharing. I read many of your blog posts, cool, your blog is very good.

binance
1 month ago

Your point of view caught my eye and was very interesting. Thanks. I have a question for you.

νοιγμα λογαριασμο Binance

Thanks for sharing. I read many of your blog posts, cool, your blog is very good.

Bamboo Splinter
The Bamboo Team
The Bamboo Team
Sep 14, 2020 • 1 min read

Subscribe to Bamboo Blog

By subscribing you accept Bamboo Blog’s

Terms of Service & Privacy Policy.

You’ve been subscribed to Bamboo Blog!